Chime in on this | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34437 of 34702  at  7/23/2018 6:30:40 PM  by

lifescifund


 In response to msg 34436 by  jtrader87
view thread

Re: Chime in on this

My guess.

LNP delivery gives very good release from endosomes. The evolution of
LNP design by Tekmira was toward better endosome release. The
mechanism, which involves pH dependent ionization of LNP lipids,
mimics mechanisms used by viruses to efficiently escape endosomes to
cytoplasm.

GalNAc delivery gives rapid, focused cell uptake to hepatocytes, but
release of siRNA to cytoplasm is very slow. You need to load much
more into the endosomes to get enough released.

Also relevant here, siRNA delivered using GalNAc conjugation must be
stabilized by extensive chemical modification, whereas siRNA delivered
by LNP can be unmodified.

The greater stability to nucleases and slow continuous release from
endosomes explains the greater durability of activity for the GalNAc
conjugated siRNA.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 324
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...